Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin
- 1 August 1991
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (8) , 1039-1045
- https://doi.org/10.1016/0277-5379(91)90277-k
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell lineEuropean Journal of Cancer and Clinical Oncology, 1989
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Cis-Diamminedichloroplatinum(II) Toxicity in Human Melanoma Cells and Lymphocytes as Related to Cellular Platinum Accumulation, DNA Cross-Linking and Inhibition of DNA SynthesisActa Oncologica, 1988
- Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloro-platinum(II)Chemico-Biological Interactions, 1987
- The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexesPharmacology & Therapeutics, 1987
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- CisplatinAnnals of Internal Medicine, 1984
- Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothioneinToxicology and Applied Pharmacology, 1981
- The Mechanism of Action of Antitumor Platinum CompoundsProgress in Nucleic Acid Research and Molecular Biology, 1979